Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
CALL
Dell
DELL
$239B
| $2.76M | ﹤0.01% |
+20,000
| New | +$2.68M |
|
2027
Lantheus
LNTH
$6.51B
| $2.75M | ﹤0.01% |
34,275
+3,935
| +13% | +$289K |
|
2028
CALL
Alnylam Pharmaceuticals
ALNY
$38.3B
| $2.75M | ﹤0.01% |
11,300
-44,700
| -80% | -$7.06M |
|
2029
Globus Medical
GMED
$11.1B
| $2.74M | ﹤0.01% |
39,942
-377
| -0.9% | -$22.5K |
|
2030
Applied Optoelectronics
AAOI
$6.14B
| $2.73M | ﹤0.01% |
329,595
+12,748
| +4% | +$140K |
|
2031
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.04B
| $2.73M | ﹤0.01% |
24,754
+380
| +2% | +$41.8K |
|
2032
Trustmark
TRMK
$2.75B
| $2.73M | ﹤0.01% |
90,766
+2,683
| +3% | +$77K |
|
2033
iShares Morningstar Growth ETF
ILCG
$3B
| $2.72M | ﹤0.01% |
33,472
+1,106
| +3% | +$84.7K |
|
2034
Innospec
IOSP
$2.09B
| $2.72M | ﹤0.01% |
22,031
+5,031
| +30% | +$630K |
|
2035
CALL
Lincoln National
LNC
$7.92B
| $2.72M | ﹤0.01% |
87,400
+8,000
| +10% | +$242K |
|
2036
Kilroy Realty
KRC
$4.59B
| $2.71M | ﹤0.01% |
86,935
-17,991
| -17% | -$598K |
|
2037
CALL
Bio-Techne
TECH
$11.2B
| $2.71M | ﹤0.01% |
37,800
-19,200
| -34% | -$1.41M |
|
2038
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$679M
| $2.71M | ﹤0.01% |
51,704
+10,456
| +25% | +$567K |
|
|
PYCR
2039
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $2.7M | ﹤0.01% |
212,784
-29,463
| -12% | -$441K |
|
2040
VanEck Emerging Markets High Yield Bond ETF
HYEM
$522M
| $2.7M | ﹤0.01% |
141,076
+15,257
| +12% | +$290K |
|
2041
Modine Manufacturing
MOD
$9.46B
| $2.7M | ﹤0.01% |
26,915
-88,063
| -77% | -$8.45M |
|
2042
Northwest Bancshares
NWBI
$2.33B
| $2.69M | ﹤0.01% |
232,577
+15,881
| +7% | +$175K |
|
2043
Varonis Systems
VRNS
$4.67B
| $2.68M | ﹤0.01% |
55,957
+1,778
| +3% | +$78.7K |
|
2044
PUT
Yum China
YUMC
$15.7B
| $2.68M | ﹤0.01% |
87,000
| – | – |
|
2045
Algonquin Power & Utilities
AQN
$4.59B
| $2.68M | ﹤0.01% |
455,841
-25,536
| -5% | -$158K |
|
2046
Eastern Bankshares
EBC
$5.27B
| $2.67M | ﹤0.01% |
191,224
-72,083
| -27% | -$958K |
|
|
ARCH
2047
DELISTED
Arch Resources, Inc.
ARCH
| $2.67M | ﹤0.01% |
17,561
-1,059
| -6% | -$170K |
|
2048
Ultrapar
UGP
$6.66B
| $2.67M | ﹤0.01% |
682,994
-1,258
| -0.2% | -$6.04K |
|
2049
Patria Investments
PAX
$1.72B
| $2.67M | ﹤0.01% |
221,370
+212,217
| +2,319% | +$2.8M |
|
|
SEM
2050
DELISTED
Select Medical
SEM
| $2.66M | ﹤0.01% |
140,967
+15,891
| +13% | +$271K |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.